White House trade adviser Peter Navarro said on Thursday that the Trump administration is likely to levy tariffs on pharmaceutical imports under a "Section 232" trade investigation because it's "very ...
Original Image Link
Source:www.reuters.com
Original Image Link
Source:www.reuters.com